Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Rank in Stocks #26763
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Share Price
$1.30
Last synced: 2023-10-13
Market Cap
$38.02M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Zynerba Pharmaceuticals, Inc. (ZYNE)

Category

Stock price history for Zynerba Pharmaceuticals, Inc. (ZYNE)
Highest end of day price: $1.27 on 2023-10-01

Lowest end of day price: $28.18 on 2015-08-01
Stock price history of Zynerba Pharmaceuticals, Inc. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2023 121.20%
2022 -82.15%
2021 -16.92%
2020 -34.43%
2019 51.25%
2018 -67.91%
2017 -17.16%
2016 20.03%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$163.21 25.45%
DE
$38.00 22.72%
JP
$220.18 33.00%
CH
$21.01 11.96%
IN